These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 10983888)

  • 1. The role of chromium(V) in the mechanism of chromate-induced oxidative DNA damage and cancer.
    Sugden KD; Stearns DM
    J Environ Pathol Toxicol Oncol; 2000; 19(3):215-30. PubMed ID: 10983888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative activation of the human carcinogen chromate by arsenite: a model for synergistic metal activation leading to oxidative DNA damage.
    Sugden KD; Rigby KM; Martin BD
    Toxicol In Vitro; 2004 Dec; 18(6):741-8. PubMed ID: 15465638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione and free amino acids form stable complexes with DNA following exposure of intact mammalian cells to chromate.
    Zhitkovich A; Voitkun V; Costa M
    Carcinogenesis; 1995 Apr; 16(4):907-13. PubMed ID: 7728973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct oxidation of guanine and 7,8-dihydro-8-oxoguanine in DNA by a high-valent chromium complex: a possible mechanism for chromate genotoxicity.
    Sugden KD; Campo CK; Martin BD
    Chem Res Toxicol; 2001 Sep; 14(9):1315-22. PubMed ID: 11559048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromium (IV)-mediated fenton-like reaction causes DNA damage: implication to genotoxicity of chromate.
    Luo H; Lu Y; Shi X; Mao Y; Dalal NS
    Ann Clin Lab Sci; 1996; 26(2):185-91. PubMed ID: 8852428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of chromium(VI) and its relationship to carcinogenesis.
    Shi X; Chiu A; Chen CT; Halliwell B; Castranova V; Vallyathan V
    J Toxicol Environ Health B Crit Rev; 1999; 2(1):87-104. PubMed ID: 10081526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromium oxidation state imaging in mammalian cells exposed in vitro to soluble or particulate chromate compounds.
    Ortega R; Fayard B; Salomé M; Devès G; Susini J
    Chem Res Toxicol; 2005 Oct; 18(10):1512-9. PubMed ID: 16533014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromium-induced genotoxicity and interference in human lymphoblastoid cell (TK6) repair processes.
    El-Yamani N; Zúñiga L; Stoyanova E; Creus A; Marcos R
    J Toxicol Environ Health A; 2011; 74(15-16):1030-9. PubMed ID: 21707427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for molecular oxygen in the formation of DNA damage during the reduction of the carcinogen chromium (VI) by glutathione.
    Kortenkamp A; Casadevall M; Faux SP; Jenner A; Shayer RO; Woodbridge N; O'Brien P
    Arch Biochem Biophys; 1996 May; 329(2):199-207. PubMed ID: 8638952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromium(VI)-mediated DNA damage: oxidative pathways resulting in the formation of DNA breaks and abasic sites.
    Casadevall M; da Cruz Fresco P; Kortenkamp A
    Chem Biol Interact; 1999 Nov; 123(2):117-32. PubMed ID: 10597905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct evidence for hydroxyl radical-induced damage to nucleic acids by chromium(VI)-derived species: implications for chromium carcinogenesis.
    Molyneux MJ; Davies MJ
    Carcinogenesis; 1995 Apr; 16(4):875-82. PubMed ID: 7537182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromium(VI) reduction by catechol(amine)s results in DNA cleavage in vitro: relevance to chromium genotoxicity.
    Pattison DI; Davies MJ; Levina A; Dixon NE; Lay PA
    Chem Res Toxicol; 2001 May; 14(5):500-10. PubMed ID: 11368547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction with glutathione is a weakly mutagenic pathway in chromium(VI) metabolism.
    Guttmann D; Poage G; Johnston T; Zhitkovich A
    Chem Res Toxicol; 2008 Nov; 21(11):2188-94. PubMed ID: 18808157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinogenic chromium(VI)-induced protein oxidation and lipid peroxidation: implications in DNA-protein crosslinking.
    Mattagajasingh SN; Misra BR; Misra HP
    J Appl Toxicol; 2008 Nov; 28(8):987-97. PubMed ID: 18615841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular and extracellular factors influencing Cr(VI) and Cr(III) genotoxicity.
    Sobol Z; Schiestl RH
    Environ Mol Mutagen; 2012 Mar; 53(2):94-100. PubMed ID: 22020802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells.
    Quievryn G; Peterson E; Messer J; Zhitkovich A
    Biochemistry; 2003 Feb; 42(4):1062-70. PubMed ID: 12549927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentially deadly carcinogenic chromium redox cycle involving peroxochromium(IV) and glutathione.
    Marin R; Ahuja Y; Bose RN
    J Am Chem Soc; 2010 Aug; 132(31):10617-9. PubMed ID: 20681676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Internalization of carcinogenic lead chromate particles by cultured normal human lung epithelial cells: formation of intracellular lead-inclusion bodies and induction of apoptosis.
    Singh J; Pritchard DE; Carlisle DL; Mclean JA; Montaser A; Orenstein JM; Patierno SR
    Toxicol Appl Pharmacol; 1999 Dec; 161(3):240-8. PubMed ID: 10620481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reductive conversion of the carcinogen chromium (VI) and its role in the formation of DNA lesions.
    Kortenkamp A; Casadevall M; Da Cruz Fresco P
    Ann Clin Lab Sci; 1996; 26(2):160-75. PubMed ID: 8852426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ESR characterization and metallokinetic analysis of Cr(V) in the blood of rats given carcinogen chromate(VI) compounds.
    Sakurai H; Takechi K; Tsuboi H; Yasui H
    J Inorg Biochem; 1999 Jul; 76(1):71-80. PubMed ID: 10530008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.